U.S. FDA Approves Agios AQVESME (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and…
Psyence BioMed Announces Approval for Use of PsyLabs Psilocybin Product in Phase IIb Clinical Trial
NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq:…
Intermap Awarded Malaysian Flood Mapping Program; Indonesia ILASPP Phase 2 Evaluation Period Extended
December 18, 2025 17:30 ET | Source: Intermap Technologies Malaysian award expands…
Global study targets dengue as disease threatens nearly half the world’s population
LISMORE, Australia, Dec. 18, 2025 /PRNewswire/ -- Thousands of dengue forecasting models…
Maverick Investments and Henox Announce Phased Development of 100 MW Green Data Centre and Cable Landing Station in Tamil Nadu
Maverick Investments Limited, part of the UAE-based Siraj Holdings Group, and Henox…
Candi Solar Secures USD 58.5 Million from International Finance Corporation (IFC) to Power Next Growth Phase
Candi Solar, a leading clean energy company specialising in distributed solar solutions…
Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as…
Ajmera Realty launches a premium and mid-segment residential project; records 81% sell-out within 24 hours
MUMBAI, India, Dec. 11, 2025 /PRNewswire/ -- In a recent development, Ajmera Realty…
Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome
– Company to host live webcast and conference call Monday, December 15,…
Mutuum Finance (MUTM) Completes Smart Contracts in Preparation for Q4 2025 Testing
Dubai, UAE, Dec. 14, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a…